Engineering Liposomes and Nanoparticles for Biological Targeting

被引:52
作者
Jolck, Rasmus I. [1 ]
Feldborg, Lise N. [1 ]
Andersen, Simon [1 ]
Moghimi, S. Moein [2 ]
Andresen, Thomas L. [1 ]
机构
[1] Tech Univ Denmark, Dept Micro & Nanotechnol, DTU Nanotech, DK-4000 Roskilde, Denmark
[2] Univ Copenhagen, Dept Pharmaceut & Analyt Chem, Ctr Pharmaceut Nanotechnol & Nanotoxicol, DK-2100 Copenhagen O, Denmark
来源
BIOFUNCTIONALIZATION OF POLYMERS AND THEIR APPLICATIONS | 2011年 / 125卷
关键词
Biological targeting; Drug delivery; Functionalization; Liposome; Nanoparticle; AZIDE-ALKYNE CYCLOADDITION; STERICALLY STABILIZED LIPOSOMES; FOLATE RECEPTOR; IN-VITRO; POLYETHYLENE-GLYCOL; GRAFTED PEG; ANTI-HER2; IMMUNOLIPOSOMES; MONOCLONAL-ANTIBODIES; IGA1; IMMUNOGLOBULIN; COVALENT ATTACHMENT;
D O I
10.1007/10_2010_92
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Our ability to engineer nanomaterials for biological and medical applications is continuously increasing, and nanomaterial designs are becoming more and more complex. One very good example of this is the drug delivery field where nanoparticle systems can be used to deliver drugs specifically to diseased tissue. In the early days, the design of the nanoparticles was relatively simple, but today we can surface functionalize and manipulate material properties to target diseased tissue and build highly complex drug release mechanisms into our designs. One of the most promising strategies in drug delivery is to use ligands that target overexpressed or selectively expressed receptors on the surface of diseased cells. To utilize this approach, it is necessary to control the chemistry involved in surface functionalization of nanoparticles and construct highly specific functionalities that can be used as attachment points for a diverse range of targeting ligands such as antibodies, peptides, carbohydrates and vitamins. In this review we provide an overview and a critical evaluation of the many strategies that have been developed for surface functionalization of nanoparticles and furthermore provide an overview of how these methods have been used in drug delivery systems.
引用
收藏
页码:251 / 280
页数:30
相关论文
共 148 条
[1]   Recent advances in tumor vasculature targeting using liposomal drug delivery systems [J].
Abu Lila, Amr S. ;
Ishida, Tatsuhiro ;
Kiwada, Hiroshi .
EXPERT OPINION ON DRUG DELIVERY, 2009, 6 (12) :1297-1309
[2]  
ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582
[3]   A strain-promoted [3+2] azide-alkyne cycloaddition for covalent modification of blomolecules in living systems [J].
Agard, NJ ;
Prescher, JA ;
Bertozzi, CR .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (46) :15046-15047
[4]   Production of soluble ScFvs with C-terminal-free thiol for site-specific conjugation or stable dimeric ScFvs on demand [J].
Albrecht, H ;
Burke, PA ;
Natarajan, A ;
Xiong, CY ;
Kalicinsky, M ;
DeNardo, GL ;
DeNardo, SJ .
BIOCONJUGATE CHEMISTRY, 2004, 15 (01) :16-26
[5]  
Allen TM, 2002, CELL MOL BIOL LETT, V7, P889
[6]   A NEW STRATEGY FOR ATTACHMENT OF ANTIBODIES TO STERICALLY STABILIZED LIPOSOMES RESULTING IN EFFICIENT TARGETING TO CANCER-CELLS [J].
ALLEN, TM ;
BRANDEIS, E ;
HANSEN, CB ;
KAO, GY ;
ZALIPSKY, S .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1237 (02) :99-108
[7]   Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs [J].
Andresen, TL ;
Davidsen, J ;
Begtrup, M ;
Mouritsen, OG ;
Jorgensen, K .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) :1694-1703
[8]   Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release [J].
Andresen, TL ;
Jensen, SS ;
Jorgensen, K .
PROGRESS IN LIPID RESEARCH, 2005, 44 (01) :68-97
[9]  
ANTONY AC, 1992, BLOOD, V79, P2807
[10]  
BAENZIGER J, 1974, J BIOL CHEM, V249, P7270